Article
Mechanisms by which the G333D mutation in human immunodeficiency virus type 1 Reverse transcriptase facilitates dual resistance to zidovudine and lamivudine.
Antimicrobial agents and chemotherapy - 1 Jan 2008
Zelina Shannon, Sheen Chih-Wei, Radzio Jessica, Mellors John W, Sluis-Cremer Nicolas
Abstract excerpt
Recent studies have identified a role for mutations in the connection and RNase H domains of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) resistance to nucleoside analog RT inhibitors (NRTI). To provide insight into the biochemical mechanism(s) involved, we investigated the effect of the G333D mutation in the connection domain of RT on resistance to zidovudine (AZT) and lamivudine (3TC)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
